SCHEMBL25974309

SCHEMBL25974309

Cc1c(F)cc(F)cc1OC(F)F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.35
PDE10A Q9Y233 1/20 0.35
OXTR P30559 4/20 0.35
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 2/20 0.33
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HTT P42858 1/20 0.33
HDAC4 P56524 1/20 0.32
NR1H2 P55055 1/20 0.32
NR1H3 Q13133 1/20 0.32
P2RX7 Q99572 1/20 0.32
BACE1 P56817 2/20 0.32
APP P05067 1/20 0.32
HDAC1 Q13547 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
RAPGEF4 Q8WZA2 1/20 0.31
KIT P10721 1/20 0.30
AVPR1A P37288 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25974324 0.83 MKNK1 (0.33) OXTRKMT2AALDH1A1MEN1MAPT
SCHEMBL14033406 0.83 KMT2A (0.36) KMT2AALDH1A1MEN1MAPTSMN1; SMN2
SCHEMBL25974426 0.79 MKNK2 (0.37) KMT2A
SCHEMBL25974443 0.76 OXTR (0.33) OXTRKMT2AMEN1MAPTHDAC4
SCHEMBL13086666 0.76 TUBB1 (0.39) PDE2APDE10AOXTRKMT2AMEN1
SCHEMBL25974321 0.75 MKNK2 (0.35) OXTRBACE1AVPR1A
SCHEMBL25974440 0.74 OXTR (0.32) OXTRAVPR1A
SCHEMBL6519254 0.74 RAPGEF4 (0.32) HDAC4RAPGEF4
SCHEMBL25974427 0.73 MKNK2 (0.37) OXTRAVPR1A
SCHEMBL25974428 0.72 OXTR (0.46) OXTRAVPR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154282-A1 COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS THERAS, INC. (US) 2023-08-17 WO disclosed